Recent updates on the significance of kras mutations in colorectal cancer biology

Abstract

The most commonly mutated isoform of RAS among all cancer subtypes is KRAS. In this review, we focus on the special role of KRAS mutations in colorectal cancer (CRC), aiming to collect recent data on KRAS‐driven enhanced cell signalling, in vitro and in vivo research models, and CRC development‐related processes such as metastasis and cancer stem cell formation. We attempt to cover the diverse nature of the effects of KRAS mutations on age‐related CRC development. As the incidence of CRC is rising in young adults, we have reviewed the driving forces of ageing‐depend-ent CRC.